EFFECTS OF BACK EXTENSION MUSCLE ENDURANCE EXERCISE AND McKENZIE THERAPY ON SELECTED BIOMARKERS AND CLINIC OUTCOMES IN LONG-TERM LOW-BACK PAIN

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202208757153267

Enrollment

Registered

2022-08-25

Start date

2020-12-10

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

McKenzie Extension Protocol

Static back extensors endurance

Dynamic back extensors endurance

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of chronic non-specific LBP who were between the ages of 20 and 65 years Patients without any obvious deformities affecting the trunk or upper and lower extremities

Exclusion criteria

Exclusion criteria: Patients having a known co-morbidity or reported history of cardiovascular disease contraindicating exercise Patients being pregnant, previous back surgery, previous experience of the McKenzie therapy Patients having directional preference for flexion or no directional preference based on the McKenzie Assessment

Design outcomes

Primary

Measure	Time frame
Pain intensity	—

Secondary

Measure	Time frame
Level of serum creatinine kinase, IL4, and IL10, Back Extension Muscles’ Endurance, Activity Limitation, Participation Restriction, and General Health Status.	—

Countries

Nigeria

Contacts

Public ContactMistura Olaoye

Clinician

olaoyemst@yahoo.com08130708507

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026